≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Impacted cerumen

DOID EFO Endpoint Browser PheWeb

H8_CERUMEN

auditory system disease: Pathological processes of the ear, the hearing, and the equilibrium system of the body.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H61.2
  • Hospital discharge: ICD-9 — 3804
  • Hospital discharge: ICD-8 — 38710
  • Cause of death: ICD-10 — H61.2
  • Cause of death: ICD-9 — 3804
  • Cause of death: ICD-8 — 38710

2 out of 7 registries used, show all original rules.

3743

4. Check minimum number of events

None

3743

5. Include endpoints

None

3743

6. Filter based on genotype QC (FinnGen only)

3743

Control definitions (FinnGen only)

Control exclude
H8_EXTERNAL

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H61
Name in latin
Cerumen obturans

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 28534 13931 14491
Only index persons 24697 12195 12502
Unadjusted period prevalence (%)
Whole population 0.40 0.40 0.40
Only index persons 0.46 0.45 0.48
Median age at first event (years)
Whole population 60.28 63.18 57.60
Only index persons 63.70 66.23 61.23

-FinnGen-

Key figures

All Female Male
Number of individuals 3743 1809 1934
Unadjusted period prevalence (%) 0.74 0.62 0.85
Median age at first event (years) 69.00 67.24 70.65

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
3302
Matched controls
33020
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H61.2
ICD-10 Finland
Impacted cerumen
5131.8
323.0
3273
665
Z01.1
ICD-10 Finland
Examination of ears and hearing
4.3
210.8
925
2722
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
3.8
209.1
1091
3751
TDA90
NOMESCO Finland
Removal wax from ear
25.9
199.4
283
119
H81
ICPC
Excessive ear wax
3.7
182.1
998
3502
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
7.0
172.3
458
741
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
5.4
172.2
576
1249
DFF00
NOMESCO Finland
Pure tone audiometry
4.7
168.1
641
1601
H60.8
ICD-10 Finland
Other otitis externa
19.0
159.0
249
141
H60.3
ICD-10 Finland
Other infective otitis externa
22.7
137.9
203
95
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.9
131.7
1028
4473
UDC00
NOMESCO Finland
Ear microscopy
4.5
118.8
465
1163
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.3
111.9
458
1192
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
7.1
111.0
286
433
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
5.9
109.8
328
605
H60.9
ICD-10 Finland
Otitis externa, unspecified
5.3
100.3
330
681
DAX08
NOMESCO Finland
Fitting of hearing aid
4.9
97.9
344
763
H13
ICPC
Plugged feeling ear
2.5
86.5
820
3839
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.0
83.3
557
2108
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.7
72.4
567
2354
DFF15
NOMESCO Finland
Speech audiometry
4.3
72.1
286
711
Z97.4
ICD-10 Finland
Presence of external hearing-aid
3.8
64.4
293
823
H61.8
ICD-10 Finland
Other specified disorders of external ear
21.7
61.6
91
43
R5120
NOMESCO Finland
Preparation of an aid
5.4
59.8
188
364
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
5.5
59.1
182
344
SPAT1172
SPAT
Guidance concerning hydration
5.1
53.0
175
358
SPAT1234
SPAT
Support of social functional capacity
3.2
48.8
271
886
H60
ICD-10 Finland
Otitis externa
4.1
47.0
193
493
SPAT1360
SPAT
Extensive global examination
2.7
45.1
335
1325
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
6.6
44.9
119
186
A98
ICPC
Health maint/preventive medicine
2.4
43.3
3076
28051
H91.1
ICD-10 Finland
Presbycusis
2.8
42.7
306
1182
H65.3
ICD-10 Finland
Chronic mucoid otitis media
5.0
39.8
132
272
H25.8
ICD-10 Finland
Other senile cataract
2.1
38.6
467
2358
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
37.9
627
3584
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
5.3
37.7
118
228
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.2
37.3
204
658
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.8
37.1
259
983
H71
ICD-10 Finland
Cholesteatoma of middle ear
8.4
35.9
80
97
H02
ICPC
Hearing complaint
2.0
35.5
491
2615
H66.9
ICD-10 Finland
Otitis media, unspecified
2.9
35.5
229
827
J01DB01
ATC
cefalexin; oral
1.7
34.9
2546
22035
XF640
NOMESCO Finland
NA
3.7
34.2
155
432
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
3.3
32.0
169
532
SPAT1310
SPAT
Counselling related to known health issue
1.6
31.8
1029
7192
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
3.9
31.0
131
344
H92.0
ICD-10 Finland
Otalgia
2.9
30.7
192
679
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
4.0
30.6
126
323
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
30.5
1445
11065
N07CA01
ATC
betahistine; oral
2.3
30.2
293
1329
R5140
NOMESCO Finland
Monitoring the use of the aid
2.1
29.7
349
1729
H29
ICPC
Ear symptom/complaint other
2.1
29.3
371
1897
M75
ICD-10 Finland
Shoulder lesions
3.2
29.1
163
535
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
29.0
1486
11541
L28
ICPC
Limited function/disability (L)
1.8
28.3
570
3451
H91.9
ICD-10 Finland
Hearing loss, unspecified
2.9
27.8
175
621
DBD20
NOMESCO Finland
Plastic repair of external auditory canal
38.2
27.1
34
9
E0000UV
ATC
NA
1.5
27.1
1188
8861
H60.4
ICD-10 Finland
Cholesteatoma of external ear
52.1
26.2
31
6
H01
ICPC
Ear pain/earache
2.1
25.8
329
1686
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.5
25.5
205
843
H65.2
ICD-10 Finland
Chronic serous otitis media
6.2
25.4
69
113
J01CA04
ATC
amoxicillin; systemic
1.5
25.4
2441
21440
R01AD08
ATC
fluticasone; nasal
1.6
25.1
772
5257
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
25.1
485
2886
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
3.8
24.7
108
293
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
11.4
24.6
46
41
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.6
24.2
707
4746
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.2
23.9
244
1133
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
23.9
569
3608
H04
ICPC
Ear discharge
3.1
23.8
137
459
DC1AD
NOMESCO Finland
Temporalbone CT
8.8
23.7
51
59
J20
ICD-10 Finland
Acute bronchitis
2.1
23.7
299
1525
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
4.8
23.0
77
162
H60.5
ICD-10 Finland
Acute otitis externa, noninfective
9.5
23.0
47
50
Z96.2
ICD-10 Finland
Presence of otological and audiological implants
40.4
22.7
28
7
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
22.6
818
5779
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
22.6
528
3326
SPAT1312
SPAT
General health counselling
1.5
22.6
979
7212
N02BE01
ATC
paracetamol; systemic, rectal
1.5
22.5
2646
23868
SPAT1043
SPAT
Audiometry
1.8
22.3
389
2232
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.8
22.0
448
2705
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.1
21.7
265
1329
I78.1
ICD-10 Finland
Naevus, non-neoplastic
3.5
21.4
103
303
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
4.5
21.4
76
171
R01AD09
ATC
mometasone; nasal
1.5
21.0
1194
9271
AA1AD
NOMESCO Finland
CT of head and brain
1.5
20.9
791
5629
SPAT1231
SPAT
Assessment of adjustments needed in living environment
3.4
20.7
104
317
S02CA02
ATC
flumetasone and antiinfectives; otic
2.3
20.5
187
823
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.9
20.4
319
1761
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
19.6
732
5181
H93.1
ICD-10 Finland
Tinnitus
2.2
19.4
205
966
J01MA01
ATC
ofloxacin; systemic
1.9
19.3
284
1534
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
19.3
304
1681
A02BC02
ATC
pantoprazole; systemic
1.4
19.1
1920
16451
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
19.0
877
6493
Z04
ICD-10 Finland
Examination and observation for other reasons
4.0
19.0
77
197
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.1
18.8
213
1034
UKC02
NOMESCO Finland
Cystoscopy
1.6
18.4
549
3678
SPAT1153
SPAT
Removal of sutures
1.4
18.4
970
7371
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.8
18.2
319
1830
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
18.1
888
6645
H84
ICPC
Presbyacusis
2.6
18.1
138
552
K03.66
ICD-10 Finland
Tooth plaque
2.0
18.0
227
1155
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
2.9
17.9
111
393
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.9
17.9
286
1591
SPAT1254
SPAT
Administration of medicine
1.6
17.9
492
3226
38710
ICD-8 Finland
Other disease of ear and mastoid process, Wax in ear
+∞
17.7
17
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
17.6
991
7617
UJF30
NOMESCO Finland
Ileoscopy through colon
1.9
17.4
287
1613
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.7
17.4
117
437
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
4.5
17.0
60
135
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
4.1
17.0
66
163
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
16.9
1210
9694
M15
ICD-10 Finland
Polyarthrosis
2.2
16.9
173
804
N03AX16
ATC
pregabalin; oral
1.5
16.6
674
4838
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
16.5
1068
8400
H62.0*A46
ICD-10 Finland
Otitis externa in erysipelas
20.1
16.4
24
12
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
2.0
16.4
221
1156
J01MA12
ATC
levofloxacin; systemic
1.5
16.3
562
3887
SPAT1125
SPAT
Stoma care and guidance
3.4
16.2
79
237
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
16.0
1259
10223
H02AB04
ATC
methylprednisolone; systemic
1.6
16.0
418
2699
D01AE16
ATC
amorolfine; topical
1.7
16.0
347
2128
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.7
15.7
360
2240
R42
ICD-10 Finland
Dizziness and giddiness
1.5
15.7
677
4917
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
15.4
792
5952
G47.3
ICD-10 Finland
Sleep apnoea
1.5
15.4
553
3860
L57.0
ICD-10 Finland
Actinic keratosis
1.7
15.3
335
2057
J01AA02
ATC
doxycycline; systemic
1.4
15.3
2263
20280
J01FA10
ATC
azithromycin; systemic
1.3
15.1
1535
12951
SPAT1216
SPAT
Assessment of functional ability
1.5
15.1
517
3565
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
1.7
15.1
314
1901
J01FF01
ATC
clindamycin; systemic
1.4
15.1
734
5456
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.6
14.9
108
420
XF402
NOMESCO Finland
ECG with work load test
1.7
14.8
359
2268
Z75.1
ICD-10 Finland
Person awaiting admission to adequate facility elsewhere
3.9
14.6
60
157
S18
ICPC
Laceration/cut
1.4
14.6
1249
10239
NG2AA
NOMESCO Finland
Patella X-ray examination
2.7
14.3
101
388
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.6
14.2
366
2351
J01MA02
ATC
ciprofloxacin; systemic
1.4
14.0
1146
9308
DFE00
NOMESCO Finland
Insertion of cochlear implant
15.8
13.9
22
14
SPAT1053
SPAT
Memory test
1.5
13.8
516
3621
L03
ICPC
Low back symptom/complaint
1.4
13.8
637
4673
SPAT1167
SPAT
Insertion of urinary catheter
2.3
13.8
127
565
DFF16
NOMESCO Finland
Speech-in-noise audiometry
20.1
13.8
20
10
A04
ICPC
Weakness/tiredness general
1.6
13.7
400
2653
H72.9
ICD-10 Finland
Perforation of tympanic membrane, unspecified
5.5
13.7
40
74
S82
ICPC
Naevus/mole
1.7
13.7
331
2088
P20
ICPC
Memory disturbance
1.6
13.7
414
2768
D07XC01
ATC
betamethasone, combinations; topical
1.6
13.6
336
2136
3804A
ICD-9 Finland
Disorders of external ear, Impacted cerumen
+∞
13.5
13
*
D07AC01
ATC
betamethasone; topical
1.4
13.4
937
7405
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.0
13.2
180
948
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
13.1
880
6909
J02AC01
ATC
fluconazole; systemic
1.4
13.0
956
7613
G04BD12
ATC
mirabegron; oral
1.6
12.9
322
2049
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
12.9
993
7961
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.5
12.9
430
2941
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
12.9
494
3486
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
12.9
421
2869
H74.1
ICD-10 Finland
Adhesive middle ear disease
9.0
12.7
26
29
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
5.3
12.7
38
73
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
2.8
12.6
82
301
L82
ICD-10 Finland
Seborrhoeic keratosis
1.5
12.4
438
3033
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
12.3
526
3790
A97
ICPC
No disease
1.5
12.3
441
3067
M54
ICD-10 Finland
Dorsalgia
1.7
12.3
285
1780
H61.3
ICD-10 Finland
Acquired stenosis of external ear canal
37.7
12.2
15
*
R01AD12
ATC
fluticasone furoate; nasal
1.4
12.2
682
5179
SPAT1211
SPAT
Application of soft bandage
1.7
12.2
284
1775
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
12.1
1101
9038
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
12.0
1888
16726
A02BC05
ATC
esomeprazole; systemic
1.3
11.9
1108
9117
Z04.3
ICD-10 Finland
Examination and observation following other accident
2.8
11.9
75
271
H02AB06
ATC
prednisolone; systemic
1.3
11.9
1316
11101
SPAT1260
SPAT
Consultation of another employee
1.5
11.9
510
3675
M79.6
ICD-10 Finland
Pain in limb
1.3
11.9
948
7622
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
3.7
11.9
50
135
X58
ICD-10 Finland
Exposure to other specified factors
1.6
11.9
338
2225
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
11.8
627
4711
S29
ICPC
Skin symptom/complaint other
1.5
11.7
469
3339
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
1.5
11.5
497
3586
H68.1
ICD-10 Finland
Obstruction of Eustachian tube
4.2
11.5
42
100
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
11.4
418
2918
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
11.4
262
1632
SCA03
NOMESCO Finland
Preventive oral health care, extensive
2.1
11.3
131
646
ND1BA
NOMESCO Finland
Wrist extensive X-ray examination
2.6
11.2
78
299
J31.0
ICD-10 Finland
Chronic rhinitis
1.8
11.2
192
1095
D01BA02
ATC
terbinafine; oral; topical
1.4
11.1
672
5157
R05
ICD-10 Finland
Cough
1.4
11.1
534
3935
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
11.1
742
5794
NF1DA
NOMESCO Finland
X-ray of hips
2.6
11.1
81
320
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
2.6
11.0
79
310
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.7
11.0
210
1237
R13
ICD-10 Finland
Dysphagia
1.8
11.0
187
1066
M01AE02
ATC
naproxen; oral, rectal
1.3
10.9
1523
13208
H25.0
ICD-10 Finland
Senile incipient cataract
1.8
10.9
195
1130
3821A
ICD-9 Finland
Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media
7.8
10.8
24
31
N03AE01
ATC
clonazepam; systemic
1.9
10.8
159
860
H65.0
ICD-10 Finland
Acute serous otitis media
3.4
10.8
51
152
H70.1
ICD-10 Finland
Chronic mastoiditis
8.8
10.7
22
25
L75
ICPC
Fracture: femur
3.2
10.6
55
176
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
10.6
485
3539
SPAT1263
SPAT
Sampling
1.3
10.6
1216
10268
D07AD01
ATC
clobetasol; topical
1.5
10.5
406
2861
N40
ICD-10 Finland
Hyperplasia of prostate
1.4
10.4
679
5269
L15
ICPC
Knee symptom/complaint
1.4
10.4
559
4201
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
10.4
897
7269
J37.0
ICD-10 Finland
Chronic laryngitis
2.3
10.4
90
390
N17
ICPC
Vertigo/dizziness
1.5
10.4
332
2245
R06AX27
ATC
desloratadine; oral
1.4
10.3
622
4764
R06.0
ICD-10 Finland
Dyspnoea
1.4
10.3
701
5480
J34.2
ICD-10 Finland
Deviated nasal septum
2.0
10.3
134
692
K59.0
ICD-10 Finland
Constipation
1.8
10.3
175
996
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
10.3
379
2645
K03.81
ICD-10 Finland
Sensitive dentine
10.6
10.3
19
18
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.3
10.2
1021
8448
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
3.9
10.0
39
100
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
2.6
9.8
70
273
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
9.8
196
1174
WZA90
NOMESCO Finland
Other doctors statement
1.4
9.8
587
4490
S01BC05
ATC
ketorolac; ophthalmic
1.9
9.8
133
701
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
9.8
314
2127
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
2.6
9.8
71
282
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
4.3
9.8
35
83
P01AB01
ATC
metronidazole; oral, rectal
1.3
9.7
984
8149
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.6
9.7
254
1639
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
9.6
447
3267
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.6
9.6
258
1676
4141
FHL
Myringoplasty (also for reasons other than inflammation)
6.8
9.6
23
34
D07AC13
ATC
mometasone; topical
1.3
9.6
753
6014
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
1.7
9.6
176
1029
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.7
9.5
206
1263
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
21.7
9.3
13
6
WX110
NOMESCO Finland
Local anesthesy
1.3
9.3
1873
16854
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.6
9.3
217
1359
DEB20
NOMESCO Finland
Attico-antro-mastoidectomy and tympanotomy
13.7
9.2
15
11
R51.80
ICD-10 Finland
Headache
1.5
9.2
339
2370
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
4.1
9.1
34
84
PA7BD
NOMESCO Finland
CT angiography of neck and brain
2.6
9.1
62
238
NF1AA
NOMESCO Finland
Hip X-ray examination
1.6
9.0
264
1749
WX002
NOMESCO Finland
Sedation and analgesia
1.4
9.0
560
4306
J02AC02
ATC
itraconazole; systemic
1.4
9.0
445
3289
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.6
9.0
245
1598
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
8.9
1205
10323
SPAT1301
SPAT
No procedures
1.3
8.9
920
7615
DCD00
NOMESCO Finland
Myringoplasty
4.6
8.9
29
63
R06AE07
ATC
cetirizine; oral
1.3
8.9
1108
9401
D02AE01
ATC
carbamide; topical
1.7
8.8
171
1014
L02
ICPC
Back symptom/complaint
1.6
8.8
220
1403
D23.2
ICD-10 Finland
Benign neoplasm: Skin of ear and external auricular canal
3.4
8.8
40
118
R35
ICD-10 Finland
Polyuria
1.7
8.7
189
1161
Q90.0
ICD-10 Finland
Trisomy 21, meiotic nondisjunction
50.1
8.7
10
*
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.5
8.7
326
2285
A02BC04
ATC
rabeprazole; oral
1.6
8.7
212
1343
Z00.0
ICD-10 Finland
General medical examination
1.4
8.6
509
3876
WX320
NOMESCO Finland
Spinalanesthesy
1.3
8.6
620
4876
M54.5
ICD-10 Finland
Low back pain
1.3
8.6
803
6557
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
3.1
8.4
43
138
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
2.0
8.4
101
510
DFX00
NOMESCO Finland
Connecting cochlear implant
12.8
8.4
14
11
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
3.0
8.3
46
156
H72.2
ICD-10 Finland
Other marginal perforations of tympanic membrane
7.9
8.3
18
23
Q90.9
ICD-10 Finland
Down syndrome, unspecified
+∞
8.3
8
*
H02AB07
ATC
prednisone; oral
1.4
8.3
384
2801
M79.1
ICD-10 Finland
Myalgia
1.5
8.3
303
2109
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.9
8.2
114
607
J01DA01
ATC
[U] cefalexin; systemic
1.2
8.2
1723
15473
XG410
NOMESCO Finland
Flow-volume spirometry
1.8
8.2
126
697
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
8.2
491
3749
H81.3
ICD-10 Finland
Other peripheral vertigo
2.2
8.2
76
345
E03
ICD-10 Finland
Other hypothyroidism
1.7
8.2
153
902
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
8.2
1744
15689
N03AX09
ATC
lamotrigine; oral
2.0
8.2
99
502
H60.0
ICD-10 Finland
Abscess of external ear
7.5
8.1
18
24
L01
ICPC
Neck symptom/complaint
1.4
8.1
335
2392
3842A
ICD-9 Finland
Other disorders of tympanic membrane, Perforation of tympanic membrane
8.1
8.1
17
21
H65.4
ICD-10 Finland
Other chronic nonsuppurative otitis media
6.8
8.1
19
28
N05AH03
ATC
olanzapine; systemic
1.8
8.0
128
715
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.7
8.0
169
1031
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
8.0
155
921
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.5
8.0
273
1875
L76
ICPC
Fracture: other
2.2
8.0
79
366
G44.2
ICD-10 Finland
Tension-type headache
1.5
8.0
294
2049
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.9
7.9
110
589
SPAT1229
SPAT
Assessment of need for aid
1.5
7.9
242
1624
R74
ICPC
Upper respiratory infection acute
1.3
7.8
624
4973
CKW99
NOMESCO Finland
Other operation on choroid, vitreous body and retina
4.3
7.8
27
63
DCD10
NOMESCO Finland
Tympanoplasty
8.5
7.8
16
19
D82
ICPC
Teeth/gum disease
1.3
7.7
815
6743
L16
ICPC
Ankle symptom/complaint
1.5
7.7
253
1723
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
2.4
7.6
63
269
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
7.6
788
6502
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.5
7.6
283
1981
J01FA09
ATC
clarithromycin; systemic
1.3
7.6
766
6303
J01DC02
ATC
cefuroxime; systemic
1.8
7.6
133
768
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
7.5
393
2931
H10
ICD-10 Finland
Conjunctivitis
1.7
7.5
147
877
Z01.2
ICD-10 Finland
Dental examination
1.2
7.5
1033
8820
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.5
7.5
235
1583
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
7.5
618
4948
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.4
7.5
379
2810
TQW99
NOMESCO Finland
Other minor procedure on skin
1.7
7.5
145
865
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.4
7.4
426
3230
J31.2
ICD-10 Finland
Chronic pharyngitis
5.0
7.4
22
44
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
2.8
7.4
45
164
H80.9
ICD-10 Finland
Otosclerosis, unspecified
3.4
7.3
33
98
38798
ICD-8 Finland
Other disease of ear and mastoid process, Alii definiti
+∞
7.3
7
*
RK420
NOMESCO Finland
NA
9.4
7.3
14
15
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.3
7.3
537
4233
E000001
ATC
NA
1.3
7.2
512
4007
T16
ICD-10 Finland
Foreign body in ear
3.4
7.2
33
99
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
7.2
665
5407
A06AC51
ATC
ispaghula, combinations; systemic
1.8
7.2
124
712
H60.1
ICD-10 Finland
Cellulitis of external ear
3.5
7.2
31
89
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
2.0
7.1
89
459
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.3
7.1
527
4153
D10.09
ICD-10 Finland
Benign tumor of the lip UNS
7.9
7.1
15
19
UJF32
NOMESCO Finland
Coloscopy
1.3
7.1
705
5784
DFF59
NOMESCO Finland
Other assessment of balance
3.5
7.1
31
90
J01DC04
ATC
cefaclor; oral
2.9
7.1
39
134
L17
ICPC
Foot/toe symptom/complaint
1.3
7.1
674
5500
A03FA02
ATC
cisapride; oral, rectal
1.5
7.1
215
1443
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.7
7.0
137
820
S21
ICPC
Skin texture symptom/complaint
1.4
7.0
323
2357
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.0
7.0
88
456
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
7.0
698
5730
B01AF02
ATC
apixaban; oral
1.4
7.0
289
2067
M01AH05
ATC
etoricoxib; oral
1.2
7.0
1465
13068
SPAT1325
SPAT
Vaccination
1.2
7.0
1045
9000
N05BA06
ATC
lorazepam; systemic, sublingual
1.7
6.9
138
831
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.0
6.8
80
402
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.6
6.8
158
990
DBB00
NOMESCO Finland
Excision of lesion of external auditory canal
10.9
6.8
12
11
N05BA12
ATC
alprazolam; oral
1.5
6.8
239
1656
H91
ICD-10 Finland
Other hearing loss
3.2
6.7
33
105
R02
ICPC
Shortness of breath/dyspnoea
1.4
6.7
326
2402
ELB50
NOMESCO Finland
Total parotidectomy
7.2
6.7
15
21
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
3.9
6.7
25
64
R55
ICD-10 Finland
Syncope and collapse
1.4
6.6
302
2198
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.3
6.6
461
3600
H28
ICPC
Limited function/disability (H)
3.1
6.6
34
112
DFX03
NOMESCO Finland
Review, maintenance and user education for hearing aid
5.9
6.6
17
29
38700
ICD-8 Finland
Other disease of ear and mastoid process, Cholesteatoma of ear
5.5
6.6
18
33
H03AA01
ATC
levothyroxine sodium; systemic
1.3
6.5
581
4692
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.7
6.5
126
753
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.3
6.5
401
3068
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
1.8
6.5
109
622
J01AA04
ATC
lymecycline; systemic
1.4
6.5
285
2064
ACC51
NOMESCO Finland
Release of median nerve
1.6
6.5
161
1031
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.6
6.4
175
1145
XKD00
NOMESCO Finland
Uroflowmetry
1.3
6.4
480
3785
M75.8
ICD-10 Finland
Other shoulder lesions
2.0
6.4
75
378
D07CC01
ATC
betamethasone and antibiotics; topical
1.4
6.4
303
2221
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
2.4
6.4
50
211
AA1XD
NOMESCO Finland
Other special CT of head and brain
4.7
6.4
20
43
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
14.3
6.4
10
7
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
6.4
451
3531
H66
ICD-10 Finland
Suppurative and unspecified otitis media
2.1
6.4
63
297
H70
ICPC
Otitis externa
2.3
6.3
52
224
ZXC15
NOMESCO Finland
Use of photodynamic technique
2.5
6.3
48
197
Z97.2
ICD-10 Finland
Presence of dental prosthetic device (complete)(partial)
2.0
6.3
78
401
N05AH04
ATC
quetiapine; oral
1.4
6.3
360
2725
H95.0
ICD-10 Finland
Recurrent cholesteatoma of postmastoidectomy cavity
18.0
6.3
9
5
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.7
6.2
121
722
C09CA06
ATC
candesartan; oral
1.3
6.2
529
4244
R03AC02
ATC
salbutamol; inhalant
1.2
6.2
1376
12289
D06BB10
ATC
imiquimod; topical
1.7
6.2
119
708
R60.0
ICD-10 Finland
Localized oedema
1.4
6.2
295
2164
M01AB05
ATC
diclofenac; systemic, rectal
1.2
6.2
1748
15974
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
1.9
6.2
86
463
ZXA10
NOMESCO Finland
Bilateral
1.3
6.2
516
4130
S97
ICPC
Chronic ulcer skin
1.6
6.2
147
929
38210
ICD-8 Finland
Chronic otitis media with mastoiditis
5.0
6.2
18
36
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.0
6.2
73
370
K03.64
ICD-10 Finland
Dental calculus supragingival
1.3
6.2
629
5167
S01EE01
ATC
latanoprost; ophthalmic
1.5
6.2
178
1183
S77
ICPC
Malignant neoplasm of skin
2.8
6.2
37
135
3853A
ICD-9 Finland
Other disorders of middle ear and mastoid, Cholesteatoma of middle ear and mastoid
5.3
6.1
17
32
R4130
NOMESCO Finland
Speech therapy
2.1
6.1
64
309
NK4EA
NOMESCO Finland
Joint X-ray examintion with load or wrench not elsewhere classified
3.3
6.1
28
85
P85
ICPC
Mental retardation
5.7
6.1
16
28
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.9
6.1
87
470
J33.8
ICD-10 Finland
Other polyp of sinus
2.3
6.1
53
235
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
1.9
6.1
87
473
F32
ICD-10 Finland
Depressive episode
1.8
6.1
104
601
WX722
NOMESCO Finland
PEEP
1.7
6.0
123
748
H66.1
ICD-10 Finland
Chronic tubotympanic suppurative otitis media
4.9
6.0
18
37
SPAT1147
SPAT
Destruction of skin lesion with external methods
2.3
6.0
52
229

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1033
3773
3.40
221.16
5.1
4.6
%
33.1
33.1
0.00
488
2509
(3019225) pH of Specimen
864
3214
3.19
175.20
5.0
4.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
826
3911
2.43
99.15
6.8
7.7
—
—
—
0
0
(3013512) EKG study
1502
9283
2.03
91.02
5.0
4.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
410
1500
2.95
81.64
4.8
4.5
mmol/l
24.6
24.7
0.43
358
1400
(3014271) Vancomycin [Susceptibility]
118
191
6.35
69.84
3.4
3.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2038
14798
1.83
69.20
6.5
6.2
mmol/l
1.2
1.2
5.40
1613
13385
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
347
1280
2.89
67.65
1.9
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
363
1391
2.78
65.84
2.0
1.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1572
10709
1.81
64.46
6.4
5.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3214
27447
2.21
62.27
16.8
15.0
ml/min/173m2
75.8
76.9
1.75
2554
22618
(3022313) Gas panel - Capillary blood
412
1729
2.55
62.21
4.7
4.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1822
13313
1.72
55.80
2.3
2.1
pmol/l
99.0
93.8
3.07
763
6948
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
492
2361
2.25
54.62
4.7
4.2
kpa
5.1
5.1
0.16
425
2190
(3009343) pH of Capillary blood
488
2338
2.25
54.37
4.8
4.2
ph
7.4
7.4
0.75
24
269
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3150
27124
2.02
53.05
5.5
4.7
mu/l
2.5
2.0
0.53
2508
24567
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
474
2267
2.25
52.96
4.7
4.1
mmol/l
1.1
1.8
3.58
335
1637
(3019309) Folate [Moles/volume] in Red Blood Cells
1029
6508
1.80
51.58
2.0
1.8
nmol/l
1057.5
1168.2
2.70
538
4888
(3019550) Sodium [Moles/volume] in Serum or Plasma
3455
30988
2.49
50.06
20.8
18.7
mmol/l
139.4
139.6
2.34
3302
30189
(3023103) Potassium [Moles/volume] in Serum or Plasma
3459
31051
2.50
49.82
20.9
18.8
mmol/l
4.0
4.0
0.21
3297
30194
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2092
16332
1.64
46.05
7.0
6.9
mmol/l
1.2
1.2
4.81
1598
13769
(3007461) Platelets [#/volume] in Blood
3579
32841
3.05
46.01
26.6
23.2
e9/l
242.9
245.8
1.80
3452
31889
(3037467) Urinalysis macro (dipstick) panel - Urine
2580
21256
1.69
45.82
5.3
4.5
—
—
—
0
0
(3035941) MCH [Entitic mass]
3579
32856
3.04
45.67
26.5
23.1
pg
30.4
30.3
0.72
3480
32296
(3026361) Erythrocytes [#/volume] in Blood
3579
32858
3.04
45.63
26.6
23.2
e12/l
4.4
4.4
4.12
3437
31785
(3010813) Leukocytes [#/volume] in Blood
3579
32865
3.03
45.47
26.7
23.2
e9/l
6.8
6.8
0.12
3439
31792
(3000963) Hemoglobin [Mass/volume] in Blood
3579
32866
3.03
45.45
26.8
23.3
g/l
133.2
134.0
2.78
3474
32312
(3024731) MCV [Entitic volume]
3578
32853
3.02
45.43
26.6
23.1
fl
91.3
91.2
1.05
3478
32293
(3018010) Neutrophils/100 leukocytes in Blood
1905
14568
1.63
45.29
6.3
5.9
%
58.0
57.6
0.59
1647
13584
(40768804) Tissue Pathology biopsy report
1623
11948
1.63
44.90
2.5
2.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
1891
14471
1.62
44.54
6.9
6.3
%
8.7
8.8
0.45
1637
13503
(3002030) Lymphocytes/100 leukocytes in Blood
1925
14796
1.62
44.52
6.8
6.1
%
27.0
27.2
0.35
1656
13732
(3013707) Erythrocyte sedimentation rate by Westergren method
2684
22416
1.70
44.52
4.9
4.1
mm/h
13.1
13.2
0.08
2240
20616
(3006504) Eosinophils/100 leukocytes in Blood
1882
14400
1.62
44.24
6.4
6.0
%
2.9
2.9
0.04
1626
13389
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3347
29927
2.12
43.81
18.1
15.8
mg/l
24.7
25.5
0.69
2699
24092
(3017732) Neutrophils [#/volume] in Blood
409
1985
2.19
43.70
3.0
3.2
e9/l
4.3
4.2
0.25
155
1504
(3022096) Basophils/100 leukocytes in Blood
1836
14003
1.61
43.43
6.7
6.1
%
0.7
0.7
0.25
1572
13043
(40761511) CBC panel - Blood by Automated count
3408
30704
2.23
43.41
18.5
15.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3464
31465
2.35
42.42
12.1
10.8
u/l
27.2
25.7
0.61
3159
30214
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1124
7629
1.68
42.20
2.5
2.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2790
23705
1.70
41.59
7.7
7.5
u/l
80.5
81.4
0.49
2473
22251
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2270
18370
1.60
40.68
3.6
3.2
u/l
51.3
51.9
0.11
1930
16860
(3009542) Hematocrit [Volume Fraction] of Blood
3044
26595
1.77
39.78
18.7
17.2
%
39.8
39.1
4.00
1815
17889
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
142
425
3.43
39.24
1.7
2.2
mg/l
18.6
24.1
0.55
19
103
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1629
12285
1.58
38.93
4.9
4.0
ng/l
45.0
94.4
0.78
1262
9064
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3206
28556
1.86
37.82
5.5
4.8
mmol/l
6.0
6.0
0.17
2531
25702
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3095
27285
1.78
37.73
4.5
4.1
mmol/l
1.3
1.3
0.56
2458
24579
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3200
28512
1.84
37.35
5.0
4.5
mmol/l
4.5
4.5
1.09
2562
26101
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3253
29215
1.87
35.85
5.4
5.1
mmol/l
2.6
2.6
0.99
2597
26593
(4146454)
121
349
3.55
35.40
2.7
2.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3169
28270
1.79
35.26
5.4
4.5
mmol/l
1.5
1.4
0.50
2538
25697
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1637
12568
1.54
34.83
2.5
2.3
nmol/l
79.5
78.0
1.06
1204
11163
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3070
27199
1.72
34.29
7.1
6.2
mmol/mol
40.3
40.4
0.35
2463
24949
(3044640) Blood type and Crossmatch panel - Blood
1344
9921
1.55
33.95
2.5
2.6
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
2456
20671
1.55
33.50
5.6
4.8
e6/l
991.5
1896.2
0.72
26
345
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
392
2087
1.98
32.31
1.8
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1094
7866
1.55
30.33
1.6
1.6
nmol/l
21.5
20.3
1.30
740
6693
(3013115) Eosinophils [#/volume] in Blood
1951
15845
1.48
29.94
6.4
6.0
e9/l
0.2
0.2
0.21
1563
13755
(3020564) Creatinine [Moles/volume] in Serum or Plasma
3412
31494
1.94
29.22
18.7
18.6
umol/l
82.2
80.5
1.68
3412
31483
(3007853) Bacteria identified in Skin by Aerobe culture
582
3636
1.71
28.37
2.1
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
553
3407
1.73
28.35
1.6
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1282
9680
1.49
27.67
2.3
2.2
u/l
201.4
226.9
0.50
1163
9035
(3013826) Glucose [Moles/volume] in Serum or Plasma
2227
18730
1.47
27.51
4.7
4.9
mmol/l
6.7
6.8
1.54
2106
17552
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1331
10144
1.48
27.35
3.5
3.2
ng/l
1687.1
1694.5
0.02
1021
8798
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
116
387
3.06
26.88
1.4
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
115
382
3.07
26.85
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
114
378
3.08
26.70
1.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
115
384
3.06
26.61
1.4
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2578
22437
1.48
25.77
4.4
3.9
pmol/l
15.0
14.9
0.10
2024
20178
(3005988) Vibrio sp identified in Specimen by Organism specific culture
112
379
3.02
25.34
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
111
377
3.00
24.96
1.4
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
797
5559
1.55
24.50
2.0
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2024
16920
1.43
24.44
2.9
2.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1952
16287
1.41
23.37
5.6
6.2
umol/l
11.5
12.2
1.70
1758
15426
(3006315) Basophils [#/volume] in Blood
1847
15350
1.40
22.13
6.2
5.8
e9/l
0.0
0.0
0.09
1518
13119
(3001604) Monocytes [#/volume] in Blood
1836
15283
1.40
21.57
6.2
5.8
e9/l
0.6
0.6
0.55
1509
13049
(3015377) Calcium [Moles/volume] in Serum or Plasma
1369
10859
1.41
21.25
3.0
3.4
mmol/l
2.4
2.4
0.71
919
9389
(3004588) Protein electrophoresis panel - Serum or Plasma
391
2361
1.73
21.23
2.2
2.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1873
15675
1.39
21.14
6.3
5.9
e9/l
1.9
1.9
0.25
1550
13641
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1560
12689
1.39
20.75
3.0
2.9
ug/l
137.9
141.9
0.13
1297
11612
(3032080) INR in Blood by Coagulation assay
1635
13462
1.38
19.94
8.9
10.4
inr
1.3
1.3
0.43
347
3769
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
62
173
3.63
19.18
2.5
2.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
52
128
4.11
19.16
1.2
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
101
377
2.73
19.16
2.7
4.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1099
8518
1.41
18.98
2.5
2.3
mg/l
3.0
3.0
0.20
816
7260
(3003338) MCHC [Mass/volume]
2195
24702
0.73
18.62
21.6
20.7
g/l
332.3
332.1
0.37
2182
24476
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1222
9683
1.39
18.41
2.7
2.6
u/l
58.4
58.4
0.00
1035
8907
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
407
2597
1.64
17.84
4.3
4.0
ng/l
95.8
92.7
0.20
290
2232
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
87
319
2.77
17.11
3.2
2.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
585
4121
1.50
16.51
1.3
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
94
371
2.57
16.02
1.2
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
204
1102
1.90
15.95
3.0
3.1
mg/l
41.8
111.5
0.75
174
890
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
199
1072
1.90
15.70
3.0
3.1
ratio
1.3
1.5
0.38
13
77
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
203
1101
1.89
15.69
3.0
3.2
mg/l
41.1
62.5
0.70
175
893
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
165
837
2.02
15.50
1.5
1.4
iu/ml
7.6
14.8
—
6
19
(3013650) Neutrophils [#/volume] in Blood by Automated count
2048
17862
1.32
15.43
8.8
8.8
e9/l
4.2
4.2
0.41
1677
15509
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1375
11336
1.34
15.35
6.0
5.3
ug/l
2.3
4.1
3.11
1103
10100
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
52
153
3.43
14.92
1.7
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
52
153
3.43
14.92
1.7
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
744
5593
1.41
14.74
1.4
1.5
g/l
2.4
2.5
0.72
359
3257
(3022217) INR in Platelet poor plasma by Coagulation assay
631
4633
1.44
14.21
31.6
28.0
inr
1.4
1.4
0.02
55
646
(3023520) Reticulocytes [#/volume] in Blood
444
3076
1.50
13.43
2.2
2.6
e9/l
66.7
68.4
0.46
345
2329
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1673
14375
1.30
13.22
3.9
4.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
83
340
2.47
13.16
1.3
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
827
6449
1.36
12.92
3.6
3.2
ug/l
0.9
0.8
0.42
546
4519
(3023368) Bacteria identified in Blood by Culture
1138
9317
1.32
12.76
4.2
4.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
200
1160
1.77
12.47
2.0
2.2
ug/l
360.0
703.5
1.04
181
1095
(3037522) Nuclear Ab [Titer] in Serum
506
3670
1.44
12.05
1.4
1.3
titre
572.2
520.0
0.22
118
771
(3037121) Protein [Mass/volume] in Urine
196
1149
1.74
11.78
3.4
3.4
g/l
0.3
0.3
0.32
76
493
(3049717) Cytology report of Urine Cyto stain
223
1356
1.69
11.74
2.8
2.7
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
530
3900
1.42
11.63
3.3
4.1
u/l
241.5
248.9
0.52
449
3667
(40768443) Skin Pathology biopsy report
219
1333
1.68
11.49
1.2
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
59
219
2.72
11.45
1.6
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
119
601
2.01
11.40
1.3
1.2
—
234.3
—
0
14
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
601
4547
1.38
11.18
2.8
2.6
%
22.2
22.4
0.08
479
3861
(3017354) Segmented neutrophils/100 leukocytes in Blood
77
333
2.34
10.90
2.3
3.4
%
60.6
58.7
0.22
44
205
(3022145) Colonoscopy Study observation
450
3256
1.43
10.81
1.3
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
673
5216
1.35
10.73
2.7
2.5
umol/l
13.0
12.6
0.66
564
4824
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
57
216
2.66
10.66
1.6
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
260
1687
1.58
10.57
1.4
1.3
au/ml
53.0
56.8
—
7
70
(3009445) Proteinase 3 Ab [Units/volume] in Serum
214
1325
1.65
10.54
1.4
1.5
u/ml
38.8
19.3
—
5
34
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
127
677
1.91
10.44
1.4
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
788
6291
1.32
10.21
1.4
1.3
u/ml
2.1
1.8
0.29
140
1551
(3002256) Pathology report gross observation
528
3969
1.38
10.16
1.3
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
421
3051
1.43
10.01
2.2
2.4
ug/l
5.9
7.0
0.77
221
2652
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
222
1406
1.62
10.00
1.8
1.9
ug/l
4.8
2.3
0.40
138
1230
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
36
111
3.27
9.70
1.2
1.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
199
1237
1.64
9.67
2.2
2.4
g/l
3.0
3.1
0.29
113
989
(3004789) Transferrin [Mass/volume] in Serum or Plasma
622
4839
1.34
9.58
2.7
2.5
g/l
2.3
2.3
1.49
525
4464
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
173
1046
1.69
9.35
1.7
2.2
g/l
37.5
37.4
0.03
107
904
(3019150) Specific gravity of Urine by Refractometry
516
6686
0.74
9.35
4.2
4.3
kg/l
1.0
1.0
0.13
96
1053
(3003458) Phosphate [Moles/volume] in Serum or Plasma
580
4486
1.35
9.27
6.6
5.9
mmol/l
1.1
1.1
0.25
498
4169
(4015189)
29
80
3.65
9.25
1.7
2.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
342
2420
1.45
9.24
1.6
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
35
110
3.20
9.16
1.1
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
35
110
3.20
9.16
1.1
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
451
3358
1.39
9.16
2.4
2.3
ug/g
114.8
149.4
1.92
301
2638
(3027945) Reticulocytes/100 erythrocytes in Blood
536
4105
1.36
9.13
2.3
2.7
%
1.8
1.8
0.07
407
3615
(4010399)
306
2125
1.48
9.10
1.5
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
975
8122
1.27
8.96
3.1
2.8
umol/l
5510.7
5781.9
0.06
744
6931
(3020630) Protein [Mass/volume] in Serum or Plasma
394
2879
1.41
8.92
2.4
2.5
g/l
66.5
66.1
0.42
299
2617
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
258
1738
1.52
8.89
2.7
2.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
207
1329
1.59
8.83
2.3
2.3
g/l
3.6
3.8
0.89
113
966
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
207
1330
1.59
8.81
2.3
2.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
68
307
2.24
8.78
1.2
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
207
1331
1.59
8.78
2.3
2.3
g/l
7.4
7.4
0.22
118
1006
(36660697) Celiac disease serology panel - Serum
323
2288
1.45
8.67
1.2
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
1929
21189
0.82
8.56
4.0
4.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
319
2264
1.45
8.48
2.5
2.8
g/l
10.6
10.5
0.15
266
2067
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
272
1875
1.49
8.40
2.7
2.4
au/ml
43.1
21.7
1.44
20
82
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
65
295
2.22
8.31
1.2
1.1
iu/ml
1.1
2.6
—
5
5
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
241
1628
1.51
8.21
1.5
1.7
g/l
1.6
1.5
0.24
186
1398
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
415
3105
1.38
8.16
2.5
2.2
g/l
0.2
0.2
0.98
372
2886
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
20
46
4.37
8.14
1.1
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
19
42
4.54
8.11
1.1
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
103
561
1.86
8.01
1.5
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
149
904
1.68
8.00
1.6
1.4
ug/g
252.6
272.7
0.55
84
529
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
22
56
3.95
7.87
1.1
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
193
1254
1.57
7.86
2.3
2.3
g/l
9.7
10.2
0.76
120
1068
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
23
61
3.79
7.79
1.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
125
730
1.74
7.73
1.6
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
53
228
2.34
7.70
1.7
1.7
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
19
44
4.34
7.67
2.3
2.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
837
6957
1.26
7.67
1.6
1.7
pmol/l
30798923.6
25241950.8
0.09
526
5693
(3024561) Albumin [Mass/volume] in Serum or Plasma
1572
13988
1.21
7.54
4.9
4.9
g/l
35.3
35.0
0.88
1342
12942
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
15
29
5.19
7.44
4.4
4.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
566
4494
1.31
7.44
2.1
2.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2279
24460
0.83
7.27
21.1
19.3
%
13.7
13.8
1.78
2240
23892
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
159
1007
1.60
7.24
1.4
1.6
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
18
42
4.30
7.21
2.4
2.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
254
1784
1.45
7.16
1.5
1.9
g/l
1.3
1.4
0.16
206
1624
(3009508) Creatinine [Moles/volume] in Urine
1156
10027
1.22
7.06
3.4
3.2
mmol/l
7.2
7.4
0.35
808
8376
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
124
742
1.69
7.05
1.2
1.2
u/ml
21.1
44.6
—
6
37
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
175
1142
1.56
7.02
1.8
2.4
g/l
0.3
1.0
5.78
115
982
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
172
1122
1.56
6.92
3.0
2.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
90
494
1.84
6.88
1.3
1.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
933
7935
1.23
6.86
4.0
4.1
%
86.7
86.3
0.18
905
7742
(3012516) Albumin [Mass/volume] in Urine
1094
9477
1.22
6.70
3.5
3.3
mg/l
533.0
303.8
0.73
609
6077
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
37
144
2.59
6.69
1.1
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
37
144
2.59
6.69
1.1
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
37
144
2.59
6.69
1.1
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
37
144
2.59
6.69
1.1
1.6
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
41
168
2.46
6.67
2.5
3.2
mu/l
20.8
19.5
0.09
36
160
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
115
686
1.70
6.64
1.2
1.2
u/ml
5.8
4.1
—
10
62
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
99
568
1.76
6.56
1.2
1.2
u/ml
17.3
7.5
—
7
42
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
782
6558
1.24
6.51
1.8
1.8
mg/l
1.3
1.4
0.21
558
5036
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
115
697
1.67
6.28
1.2
1.2
u/ml
2.2
7.6
1.69
14
107
(21494755) Public health laboratory ask at order entry panel
108
1745
0.61
6.15
1.3
1.3
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
37
152
2.45
6.02
1.1
1.1
u/l
17.1
31.8
1.58
29
107
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
23
73
3.16
6.01
1.3
1.6
ug/l
0.3
0.4
—
5
42
(3024869) Neuronal Ab [Presence] in Serum
20
58
3.46
6.00
1.2
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
59
295
2.02
5.99
1.1
1.2
u/l
62.7
65.0
0.09
28
204
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
17
44
3.88
5.98
1.2
1.6
ng/l
135.1
103.3
—
10
30
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
31
122
2.55
5.53
1.2
1.1
ng/l
70.0
393.5
—
9
32
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
534
4369
1.26
5.47
1.2
1.2
u/ml
25.2
13.4
0.45
135
1608
(3004809) Band form neutrophils/100 leukocytes in Blood
92
547
1.70
5.44
2.7
3.7
%
2.1
1.6
0.25
60
417
(40760888) Immunoglobulin light chains.free panel - Serum
128
827
1.57
5.44
3.3
3.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
23
78
2.96
5.41
1.8
1.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
132
862
1.55
5.36
1.6
1.6
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
34
4.13
5.35
1.1
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
13
30
4.34
5.29
1.1
1.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
47
227
2.08
5.28
1.1
1.1
—
57.7
—
0
9
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
68
374
1.83
5.26
1.5
1.5
%
63.0
62.6
0.03
40
237
(3020682) Albumin/Creatinine [Ratio] in Urine
1129
10007
1.18
5.13
4.3
4.0
mg/mmol
12.1
9.3
0.92
614
6386
(3017446) Testosterone [Moles/volume] in Serum or Plasma
287
2183
1.34
5.11
2.3
2.1
nmol/l
11.5
12.3
0.80
228
1889
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1006
11373
0.84
5.05
4.1
4.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
31
128
2.43
5.04
1.3
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
553
4588
1.24
5.00
1.3
1.2
iu/ml
33.6
38.0
0.29
140
1396
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
21
71
2.97
4.98
1.0
1.1
pmol/l
170.0
266.2
—
8
53
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
221
1621
1.39
4.96
3.1
3.3
pmol/l
4.3
4.5
0.99
174
1412
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
34
149
2.29
4.86
1.7
1.7
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
20
67
3.00
4.82
1.1
1.3
mu/l
61.7
67.1
—
8
55
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
57
307
1.87
4.74
1.1
1.5
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
170
1201
1.44
4.74
1.6
1.8
u/l
39.3
38.7
0.14
132
1038
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
13
33
3.95
4.71
1.2
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
153
2166
0.69
4.69
5.8
6.7
mmol/l
24.7
24.4
0.34
142
2009
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
199
1449
1.39
4.68
1.1
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
26
103
2.53
4.62
1.2
1.2
g/l
43.3
37.9
0.59
13
52
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
12
29
4.15
4.62
1.1
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
15
43
3.50
4.61
1.1
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
22
80
2.76
4.61
1.1
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
127
856
1.50
4.52
1.8
1.6
iu/ml
16.1
8.5
0.20
24
184
(3020891) Body temperature
87
1369
0.63
4.51
5.2
4.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
118
785
1.52
4.47
1.6
1.6
e6/l
20346.6
15014.8
0.47
66
563
(3051593) INR in Capillary blood by Coagulation assay
37
175
2.13
4.43
1.1
14.1
—
—
—
0
0
(4035726)
342
2720
1.28
4.43
1.4
1.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
134
918
1.48
4.41
5.8
5.7
mg/l
1.7
1.5
1.18
116
838
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
29
124
2.35
4.40
1.1
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
123
829
1.50
4.39
1.4
1.6
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
11
26
4.24
4.35
1.8
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
263
2027
1.32
4.31
1.5
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
60
342
1.77
4.20
1.2
1.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
29
128
2.28
4.12
1.1
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
37
181
2.05
4.09
1.2
1.5
u/l
22.3
6.5
—
8
85
(3048879) Bone marrow aspiration report
24
98
2.46
4.04
1.1
1.6
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
154
2114
0.72
3.99
3.4
3.5
g/l
129.1
127.9
0.26
148
2055
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
24
99
2.43
3.96
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
242
1872
1.31
3.89
1.2
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
31
145
2.15
3.86
1.0
1.0
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
8
11
7.29
3.86
1.0
1.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
16
54
2.97
3.84
2.2
2.2
ug/l
3.1
3.2
—
7
21
(3044290) Cell count panel - Cerebral spinal fluid
91
593
1.55
3.84
1.7
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
716
8161
0.85
3.79
4.3
4.2
estimate
0.0
0.0
0.37
257
2664
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1015
9106
1.16
3.77
4.4
4.6
%
23.3
22.0
1.67
504
4721
(3033086) Enterovirus NOS Ab [Titer] in Serum
6
5
12.02
3.76
1.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
123
859
1.45
3.72
1.5
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
23
96
2.40
3.72
1.1
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
22
90
2.45
3.71
1.1
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
96
1412
0.67
3.67
4.0
5.2
%
0.8
0.9
0.39
86
1316
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
22
91
2.43
3.63
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
22
91
2.43
3.63
1.0
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
108
742
1.47
3.57
1.7
1.9
mg/l
11.8
11.6
0.07
90
676
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
106
726
1.47
3.56
1.4
1.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
18
68
2.66
3.56
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
18
68
2.66
3.56
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
18
68
2.66
3.56
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
18
68
2.66
3.56
1.1
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
26
3.85
3.52
1.1
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
338
2764
1.24
3.51
2.1
2.2
nmol/l
377.9
373.3
0.16
278
2515
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
13
41
3.18
3.49
2.9
2.3
umol/l
14.4
17.3
0.39
13
41
(3026389) Candida sp identified in Specimen by Organism specific culture
63
386
1.64
3.46
1.3
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
37
3.25
3.34
1.1
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
117
830
1.42
3.30
1.3
1.5
g/l
1.3
1.2
1.32
110
787
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
114
805
1.43
3.29
1.3
1.5
g/l
0.2
0.2
0.27
106
766
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
59
361
1.64
3.28
1.3
1.3
nmol/l
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
79
519
1.53
3.27
1.2
1.2
u/ml
32.0
46.4
—
7
46
(40761535) Cells panel - Urine sediment
325
2669
1.24
3.26
3.2
3.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
408
3431
1.21
3.25
3.3
4.0
ug/l
9.6
21.9
1.57
286
2827
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
74
480
1.55
3.24
1.3
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
67
425
1.59
3.23
1.2
1.6
g/l
0.7
0.8
0.94
44
328
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
20
84
2.39
3.22
1.7
1.6
pmol/l
16.0
14.8
0.44
15
71
(3003327) Ova and parasites identified in Stool by Light microscopy
125
902
1.40
3.21
1.7
1.7
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
30
152
1.98
3.09
1.9
1.6
—
9.3
—
0
10
(3005322) IgE [Units/volume] in Serum or Plasma
209
1640
1.29
3.08
1.4
1.3
u/ml
295.3
232.4
0.54
196
1508
(1761482) Bacteria [#/volume] in Urine by Culture
58
910
0.63
3.07
4.5
4.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
17
68
2.51
3.04
1.4
1.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
17
68
2.51
3.04
1.1
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
178
1375
1.31
2.97
1.9
1.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1097
10044
1.13
2.91
3.3
3.3
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
10
30
3.34
2.90
1.1
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
559
6370
0.86
2.90
4.6
4.6
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
6
9
6.67
2.86
1.0
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
32
171
1.88
2.85
1.1
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
599
5272
1.16
2.83
3.4
3.1
e6/l
2.5
2.2
0.39
330
2932
(3018405) Lactate [Moles/volume] in Arterial blood
87
1234
0.70
2.82
3.9
3.6
mmol/l
1.5
1.4
0.15
87
1213
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
45
268
1.69
2.81
1.6
1.5
u/ml
28.8
22.6
—
9
57
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
266
2175
1.24
2.81
2.1
2.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
602
5303
1.16
2.81
3.7
3.4
mmol/l
0.8
0.8
0.26
531
4925
(3020779) Urea [Moles/volume] in Serum or Plasma
373
3158
1.20
2.79
8.6
7.3
mmol/l
10.7
10.3
0.36
331
3001
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
21
97
2.17
2.76
1.6
1.3
ug/l
69.3
392.4
0.62
14
49
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
10
6.01
2.70
9.5
9.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
32
175
1.84
2.68
1.2
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
102
736
1.40
2.67
1.1
1.1
—
—
—
0
0
(4034850)
65
961
0.67
2.65
9.5
11.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
242
1977
1.24
2.60
2.1
1.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
92
658
1.41
2.55
1.4
1.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
106
1428
0.73
2.54
4.0
5.2
%
1.8
1.6
0.95
97
1329
(40763480) Human metapneumovirus Ag [Presence] in Specimen
6
11
5.46
2.54
1.0
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
48
748
0.64
2.53
4.4
3.6
mg/l
21.9
28.8
1.00
34
477
(3002173) Hemoglobin [Mass/volume] in Arterial blood
268
3215
0.82
2.52
7.0
7.6
g/l
121.1
120.8
0.08
260
3091
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
46
285
1.62
2.51
1.6
1.6
—
—
—
0
0
(3017704) Immunofixation for Urine
34
194
1.76
2.50
1.4
1.5
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
65
437
1.50
2.49
4.7
4.7
umol/l
390.2
353.3
0.93
52
380
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
42
255
1.65
2.48
1.5
1.4
u/l
25.3
26.5
0.07
24
209
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
37
217
1.71
2.48
1.7
1.3
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
7
16
4.38
2.47
5.9
5.4
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
7
16
4.38
2.47
6.1
5.4
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
45
280
1.61
2.42
3.7
2.6
nmol/l
20.5
20.1
0.11
38
264
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
62
416
1.50
2.41
1.3
1.3
nmol/l
0.2
0.4
—
5
26
(3014148) Varicella zoster virus Ab [Titer] in Serum
48
304
1.59
2.41
1.2
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
131
1004
1.32
2.37
1.8
2.3
g/l
0.0
0.0
0.26
110
917
(3049242) von Willebrand panel - Platelet poor plasma
5
8
6.26
2.37
2.0
1.8
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
65
443
1.48
2.35
1.0
1.1
—
9.6
—
0
20
(3043409) Potassium [Moles/volume] in Arterial blood
75
1049
0.71
2.30
4.1
3.8
mmol/l
3.9
3.9
0.21
69
966
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
31
177
1.76
2.30
1.1
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
401
3483
1.17
2.27
1.5
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
129
998
1.30
2.21
1.4
1.2
u/ml
0.8
0.8
—
5
90
(3023383) Lactate [Moles/volume] in Pleural fluid
21
107
1.97
2.20
1.5
1.4
mmol/l
3.7
3.3
0.20
21
95
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
116
887
1.32
2.16
1.5
1.7
mg/l
2.6
3.6
0.64
79
623
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
41
258
1.60
2.14
1.1
1.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
27
462
0.58
2.14
2.1
2.4
mmol/l
105.9
105.5
0.16
27
455
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
27
152
1.78
2.11
2.3
2.3
umol/l
57.1
55.5
0.08
16
124
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
290
3393
0.84
2.11
4.0
3.6
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
18
88
2.05
2.11
1.8
1.4
%
21.3
20.9
0.03
18
68
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
206
2482
0.82
2.07
2.9
2.7
ml/min/173m2
57.5
62.3
1.10
88
1049
(3035350) Ketones [Presence] in Urine by Test strip
1409
14917
0.91
2.05
3.8
3.8
estimate
0.0
0.0
0.00
260
2762
(3016018) Differential panel - Cerebral spinal fluid
46
301
1.53
2.05
2.0
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
47
310
1.52
2.03
1.1
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
80
585
1.38
2.02
4.5
5.4
iu/ml
446.8
3399.4
—
8
80
(3042631) Mycobacterium sp identified in Specimen
64
450
1.43
2.02
3.8
2.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
27
454
0.59
2.02
2.1
2.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
30
178
1.69
1.98
1.2
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
41
264
1.56
1.97
1.1
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
41
264
1.56
1.97
1.1
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
41
264
1.56
1.97
1.1
1.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
29
171
1.70
1.96
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
29
171
1.70
1.96
1.1
1.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
28
462
0.60
1.95
2.1
2.4
mmol/l
4.1
4.1
0.15
28
455
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
51
2.36
1.95
5.8
7.5
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
9
33
2.73
1.93
1.2
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
131
1037
1.27
1.92
1.4
1.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
63
447
1.42
1.91
5.6
6.6
mg/l
10.6
12.2
2.11
56
412
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
120
941
1.28
1.90
1.8
2.3
g/l
0.0
0.0
0.00
100
858
(3027456) Digoxin [Moles/volume] in Serum or Plasma
106
818
1.30
1.89
3.0
3.1
nmol/l
0.8
0.8
0.28
58
622
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
51
349
1.47
1.87
1.1
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
297
3430
0.85
1.87
4.7
4.2
mmol/l
1.3
1.9
2.95
249
2737
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
55
384
1.44
1.83
1.3
1.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
299
3441
0.86
1.80
4.7
4.1
kpa
5.7
5.8
1.53
290
3331
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
77
572
1.35
1.80
1.3
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
83
624
1.34
1.79
1.5
1.5
mmol/l
66.1
64.9
0.08
60
505
(3020191) Ethanol [Moles/volume] in Serum or Plasma
34
215
1.59
1.79
1.1
1.4
promille
1.0
1.2
0.33
28
171
(4062490)
41
272
1.51
1.76
1.2
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
212
1788
1.20
1.75
6.9
8.9
mmol/l
24.3
24.3
0.07
195
1671
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
12
54
2.23
1.73
1.0
1.1
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
24
2.92
1.72
1.1
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
7
24
2.92
1.72
1.0
1.1
—
—
—
0
0
(4024509)
46
315
1.47
1.71
1.3
1.6
—
—
—
0
0
(4211845)
28
171
1.64
1.70
4.6
4.0
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
65
475
1.37
1.69
4.1
3.4
u/ml
756.7
1734.5
—
7
39
(3009261) Glucose [Presence] in Urine by Test strip
1440
15133
0.92
1.68
3.9
3.9
estimate
0.0
0.0
1.08
262
2715
(3018572) Chloride [Moles/volume] in Blood
55
761
0.72
1.67
4.6
7.1
mmol/l
104.0
105.3
1.20
46
669
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
197
1659
1.20
1.66
1.3
1.2
iu/ml
153.8
145.2
0.09
60
594
(3008401) Mugwort IgE Ab [Units/volume] in Serum
61
443
1.38
1.66
1.1
1.1
u/ml
0.9
1.7
0.61
36
232
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
23
134
1.72
1.66
18.5
13.1
nmol/l
836.2
791.9
0.17
23
128
(3039000) Anion gap in Blood
55
760
0.72
1.65
4.6
7.1
mmol/l
10.7
11.2
0.64
46
668
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
36
236
1.53
1.65
1.0
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
95
739
1.29
1.64
1.5
1.6
mg/l
778.2
539.4
0.58
87
695
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
116
929
1.26
1.59
1.8
2.3
g/l
0.0
0.0
0.00
100
857
(3021601) Nitrite [Presence] in Urine by Test strip
1423
14934
0.92
1.58
5.3
5.2
estimate
0.0
0.0
0.50
275
2793
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
559
6119
0.90
1.57
2.9
3.1
mmol/l
2.5
2.5
0.34
484
5339
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
24
144
1.67
1.57
1.1
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
276
3158
0.86
1.57
3.4
3.0
ng/l
211.8
229.7
0.29
248
2881
(3017143) Hepatitis C virus Ab [Presence] in Serum
330
2913
1.15
1.56
1.6
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
26
160
1.63
1.55
4.9
4.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
390
3485
1.13
1.54
1.6
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
67
501
1.34
1.54
1.2
1.2
u/ml
2.4
2.5
0.01
36
246
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
390
3487
1.13
1.53
3.0
2.9
umol/l
6.5
8.9
2.78
326
3042
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
130
1584
0.81
1.53
2.6
2.9
%
0.7
0.7
0.42
125
1513
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
53
382
1.39
1.53
1.6
1.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
16
86
1.86
1.50
2.0
1.7
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
38
259
1.47
1.48
2.5
2.6
umol/l
5.3
11.2
1.47
24
184
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
322
2852
1.14
1.47
2.3
2.4
u/l
41.3
55.2
0.37
280
2428
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
66
866
0.76
1.45
2.0
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
40
277
1.45
1.44
1.2
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
143
1714
0.83
1.44
3.4
3.6
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
5
16
3.13
1.44
3.6
3.0
mmol/l
4.6
4.3
—
5
16
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
98
781
1.26
1.43
1.3
1.5
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
6
22
2.73
1.43
1.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
9
39
2.31
1.43
1.1
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
252
2879
0.87
1.42
4.0
3.7
kpa
4.7
4.6
0.44
243
2781
(3019060) Gas panel - Arterial blood
197
2293
0.85
1.42
3.7
4.6
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
39
270
1.45
1.41
1.2
1.3
g/l
2.7
2.9
0.30
23
191
(3024139) IgG subclass 3 [Mass/volume] in Serum
39
270
1.45
1.41
1.2
1.3
g/l
0.4
0.4
0.15
24
192
(3027135) IgG subclass 1 [Mass/volume] in Serum
39
270
1.45
1.41
1.2
1.3
g/l
7.6
7.1
0.29
23
192
(3003888) Timothy IgE Ab [Units/volume] in Serum
61
457
1.34
1.41
1.1
1.1
u/ml
3.9
5.9
0.56
39
263
(3006653) Thiamine [Moles/volume] in Blood
24
149
1.61
1.40
1.1
1.2
nmol/l
135.6
138.5
0.13
24
149
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
90
713
1.27
1.39
2.0
1.7
nmol/l
39.8
41.8
0.33
78
684
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
59
441
1.34
1.39
1.1
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
34
230
1.48
1.38
1.0
1.0
mg/l
289.6
291.8
0.05
27
206
(3047181) Lactate [Moles/volume] in Blood
83
1049
0.79
1.38
4.0
6.3
mmol/l
1.4
1.3
0.44
69
912
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
185
2157
0.85
1.37
8.3
8.3
%
1.3
1.3
0.08
185
2143
(3027923) C peptide [Moles/volume] in Serum or Plasma
26
166
1.57
1.37
1.4
1.3
nmol/l
2.1
1.1
—
9
129
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
15
82
1.83
1.35
1.6
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
429
3890
1.12
1.35
1.8
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
78
610
1.28
1.34
1.2
1.3
miu/ml
207.2
225.1
0.15
28
260
(3025941) Bacteria identified in Stool by Culture
187
1603
1.18
1.34
1.2
1.3
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
38
0.00
1.34
0.0
1.2
—
17.6
—
0
32
(3021387) Prolactin [Units/volume] in Serum or Plasma
90
717
1.26
1.34
2.0
1.6
mu/l
335.5
303.4
0.30
80
660
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
82
647
1.27
1.32
1.8
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
19
113
1.68
1.31
1.1
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
6
24
2.50
1.30
1.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
75
587
1.28
1.29
1.5
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
829
7783
1.08
1.26
1.7
1.6
mmol/l
1.4
1.3
0.43
693
6484
(3028433) Virus identified in Specimen by Culture
18
107
1.69
1.25
1.1
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
268
2374
1.14
1.25
3.5
3.8
%
0.7
0.6
0.24
65
532
(3028626) Oxygen [Partial pressure] in Capillary blood
125
1042
1.21
1.24
5.7
4.3
kpa
9.1
8.4
3.13
114
974
(40761536) Microorganisms panel - Urine sediment
228
2593
0.87
1.24
5.0
4.1
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
185
2136
0.86
1.24
8.5
8.5
%
93.6
93.9
0.21
185
2127
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
605
5611
1.09
1.23
3.3
2.9
e6/l
0.8
1.2
2.20
337
3240
(44816559) Phosphatidylethanol [Mass/volume] in Blood
63
486
1.30
1.22
1.2
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
677
7251
0.92
1.22
3.4
3.8
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
186
2144
0.86
1.22
8.3
8.4
%
0.6
0.7
1.69
186
2127
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
5
19
2.63
1.21
1.2
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
156
1331
1.18
1.21
1.2
1.1
titre
28.9
154.0
—
9
33
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
28
188
1.49
1.21
1.5
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
90
729
1.24
1.19
1.3
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
476
4373
1.10
1.19
1.5
1.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
8
38
2.11
1.18
1.0
2.9
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
62
481
1.29
1.17
1.9
1.7
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
11
57
1.93
1.17
3.5
1.9
—
63.5
—
0
6
(46235355) HIV 1 and 2 tests - Meaningful Use set
454
4167
1.10
1.16
1.8
1.8
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
101
832
1.22
1.15
1.5
1.5
iu/l
26.1
27.4
0.15
84
683
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
325
2932
1.12
1.15
1.7
1.7
%
1.5
1.5
0.13
270
2537
(3003694) ABO and Rh group [Type] in Blood
747
7944
0.93
1.13
1.3
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
560
5197
1.09
1.13
2.3
2.2
s
29.8
30.0
0.48
539
5029
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
102
844
1.21
1.12
3.1
3.1
%
187.4
194.7
0.39
96
809
(3013166) Neutrophils/100 leukocytes in Synovial fluid
5
114
0.44
1.12
2.4
1.3
%
32.8
60.8
—
5
95
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
29
200
1.45
1.12
1.7
2.6
e9/l
0.4
0.2
0.54
24
174
(3023410) Appearance of Cerebral spinal fluid
41
302
1.36
1.10
2.2
2.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
26
176
1.48
1.10
1.8
1.4
pmol/l
69.9
237.0
0.49
14
55
(3015736) pH of Urine
1112
11645
0.94
1.10
3.4
3.6
ph
5.9
5.9
—
6
8
(3014576) Chloride [Moles/volume] in Serum or Plasma
390
4258
0.91
1.08
6.4
6.6
mmol/l
104.5
104.3
0.56
383
4147
(3036489) Thrombin time
133
1134
1.18
1.07
2.4
2.5
s
23.8
21.6
0.95
117
1022
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
73
587
1.25
1.06
1.3
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
861
9084
0.93
1.06
2.9
3.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
27
186
1.45
1.05
1.2
1.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
28
195
1.44
1.04
1.5
1.5
umol/l
12.8
13.8
0.37
23
185
(3025577) Chromium [Mass/volume] in Blood
30
212
1.42
1.03
2.3
2.1
ug/l
1.6
2.0
0.99
23
181
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
5
22
2.27
1.03
1.8
2.1
mg/l
2.7
1.8
—
5
15
(3007566) Smooth muscle Ab [Titer] in Serum
93
772
1.21
1.01
1.5
1.2
titre
61.2
93.8
—
8
63
(3002619) Bacteria identified in Specimen by Culture
10
53
1.89
1.01
1.0
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
27
188
1.44
1.01
1.5
1.3
u/ml
2.9
1.0
0.60
18
88
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
38
283
1.35
0.98
1.1
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
9
160
0.56
0.98
1.6
1.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
37
275
1.35
0.97
1.2
1.3
nmol/l
1.5
1.5
0.01
32
247
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
101
1194
0.84
0.95
3.2
3.2
u/ml
250.4
4277.5
1.02
92
1012
(3004716) Salmonella sp identified in Stool by Organism specific culture
119
1387
0.85
0.95
1.3
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
65
524
1.24
0.94
1.5
1.4
u/ml
111.8
117.3
0.17
15
90
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
29
208
1.40
0.94
1.7
2.6
e6/l
576.8
505.8
0.27
24
173
(3016502) Oxygen saturation in Arterial blood
322
3518
0.91
0.93
6.3
7.2
%
95.0
95.5
0.57
312
3369
(3044941) Cell count panel - Synovial fluid
64
516
1.24
0.93
1.5
1.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
13
78
1.67
0.91
1.4
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
108
922
1.18
0.89
3.3
3.7
mmol/l
24.3
24.9
0.64
94
806
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
90
756
1.20
0.89
1.4
1.5
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
29
2.07
0.89
7.2
1.9
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
361
3911
0.91
0.88
5.9
6.9
kpa
5.0
5.1
1.59
341
3711
(3027801) Oxygen [Partial pressure] in Arterial blood
361
3911
0.91
0.88
5.9
6.9
kpa
12.2
12.2
0.08
340
3714
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
998
9558
1.06
0.86
3.1
3.2
u/l
37.2
38.2
0.09
922
9043
(3023183) Ammonium ion [Moles/volume] in Plasma
84
705
1.20
0.85
2.2
2.8
umol/l
30.2
35.8
1.41
64
589
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
74
614
1.21
0.84
2.7
2.1
u/l
8501.4
3375.3
0.32
30
248
(3009214) Lutropin [Units/volume] in Serum or Plasma
82
688
1.20
0.84
1.6
1.6
u/l
5.7
9.3
4.16
56
541
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
107
919
1.17
0.84
3.0
3.0
g/l
3.6
3.6
0.05
101
871
(3021440) Promyelocytes/100 leukocytes in Blood
273
2491
1.10
0.84
3.9
4.0
%
0.1
0.1
0.87
81
707
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
36
274
1.32
0.83
1.4
1.5
nmol/l
0.3
0.3
0.34
24
209
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
10
57
1.76
0.83
1.4
1.3
%
109.0
108.3
—
10
51
(3009871) Measles virus Ab [Titer] in Serum
11
65
1.69
0.82
1.5
1.5
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
11
65
1.69
0.82
1.0
1.2
umol/l
19.7
17.1
0.68
11
57
(3010144) Erythrocytes [#/volume] in Synovial fluid
41
319
1.29
0.82
1.4
1.3
e6/l
627199.6
122773.2
0.92
22
219
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
143
1258
1.14
0.82
2.7
3.3
u/ml
0.4
0.3
0.15
84
730
(3020393) Adenovirus Ag [Presence] in Stool
8
48
1.67
0.78
1.8
1.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
363
3906
0.92
0.78
5.9
6.9
mmol/l
0.8
1.1
0.91
294
3023
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
12
74
1.62
0.78
1.1
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
918
8800
1.06
0.77
3.7
3.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
90
769
1.17
0.77
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
90
769
1.17
0.77
1.2
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
22
157
1.40
0.76
6.3
6.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
108
938
1.16
0.75
1.8
1.7
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
51
413
1.24
0.75
1.2
1.1
u/ml
0.3
2.9
4.18
17
118
(1002224) Polysomnography panel
101
873
1.16
0.75
1.1
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
92
790
1.17
0.74
1.1
1.2
—
—
—
0
0
(3010421) pH of Blood
75
884
0.85
0.73
4.6
4.6
ph
7.4
7.4
0.44
70
752
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
9
55
1.64
0.73
1.4
2.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
16
108
1.48
0.73
1.1
1.1
miu/ml
1320.5
1614.0
0.61
16
108
(3048929) Epstein Barr virus Ab [Presence] in Serum
99
858
1.16
0.72
1.5
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
24
322
0.74
0.72
1.2
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
284
2621
1.09
0.71
3.9
4.0
%
0.8
0.9
0.20
85
765
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
77
902
0.85
0.71
1.1
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
36
282
1.28
0.71
1.1
1.2
nmol/l
313.4
346.9
0.43
30
230
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
27
203
1.33
0.70
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
27
203
1.33
0.70
1.2
1.1
—
—
—
0
0
(4094501)
89
767
1.16
0.70
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
79
921
0.85
0.69
1.1
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
13
193
0.67
0.69
1.5
2.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
42
337
1.25
0.69
3.5
3.5
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
27
204
1.33
0.68
1.2
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
42
1.67
0.68
1.7
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
753
7863
0.95
0.68
4.0
3.6
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
40
320
1.25
0.67
1.0
1.6
—
1093.3
—
0
9
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
66
557
1.19
0.67
1.6
1.3
u/ml
235.5
261.2
0.29
35
319
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
77
659
1.17
0.67
1.8
1.9
iu/l
4.0
4.4
0.14
21
215
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
28
1.79
0.66
1.2
1.3
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
5
28
1.79
0.66
1.0
1.3
u/l
6.0
13.6
—
5
28
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
28
215
1.30
0.65
1.2
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
22
293
0.75
0.64
1.4
1.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
22
163
1.35
0.64
1.5
1.5
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
8
129
0.62
0.63
1.4
1.3
—
1.4
—
0
9
(3020876) Protein [Mass/time] in 24 hour Urine
34
269
1.27
0.63
2.4
1.8
—
1.3
—
0
14
(3014765) Yersinia sp identified in Stool by Organism specific culture
79
913
0.86
0.63
1.1
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
69
589
1.17
0.63
1.6
1.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
321
2998
1.08
0.62
5.6
6.8
mmol/l
1.3
1.4
0.95
303
2874
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
312
2911
1.08
0.62
1.7
1.6
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
45
369
1.22
0.62
1.2
1.7
—
3.8
—
0
5
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
22
164
1.34
0.62
1.0
1.2
u/l
12.1
15.7
0.58
17
143
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
27
208
1.30
0.62
1.6
2.3
e6/l
440.0
698.2
2.04
13
79
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
12
176
0.68
0.61
2.6
3.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
105
0.57
0.61
1.0
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
30
1.67
0.61
3.4
2.7
u/field
0.2
0.8
—
5
30
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
20
0.00
0.60
0.0
2.9
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.8
—
21.5
—
0
11
(3035637) Corticotropin [Mass/volume] in Plasma
45
371
1.22
0.60
1.8
1.6
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
21
0.00
0.60
0.0
10.9
—
181.6
—
0
15
(3020874) Milk IgE Ab [Units/volume] in Serum
20
148
1.35
0.59
1.1
1.2
u/ml
0.6
4.0
—
9
70
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
11
72
1.53
0.59
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
26
201
1.30
0.58
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
26
201
1.30
0.58
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
26
201
1.30
0.58
1.2
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
7
115
0.61
0.57
1.3
1.4
%
24.1
22.3
—
7
105
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
24
184
1.31
0.57
1.0
1.1
nmol/l
1.4
7.6
—
7
40
(3028707) Methadone [Presence] in Urine by Screen method
43
355
1.21
0.57
2.4
2.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
51
429
1.19
0.56
1.4
2.1
ug/l
16.4
25.6
1.57
46
423
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
69
796
0.86
0.56
2.7
2.3
ug/min
65.3
101.5
0.50
39
483
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
10
65
1.54
0.55
1.1
1.1
pmol/l
—
7.2
—
0
10
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
37
302
1.23
0.55
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
34
417
0.81
0.55
3.8
2.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
22
168
1.31
0.55
1.0
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
12
171
0.70
0.54
2.2
2.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
51
431
1.19
0.54
1.1
1.1
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
8
125
0.64
0.54
1.3
1.5
%
0.9
2.6
—
8
103
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
14
99
1.42
0.54
1.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
167
1820
0.91
0.53
8.1
9.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
46
386
1.19
0.53
1.5
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
64
553
1.16
0.53
4.4
3.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
12
83
1.45
0.51
1.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
15
109
1.38
0.50
1.1
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
19
247
0.77
0.50
1.3
1.5
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
6
41
1.46
0.50
1.2
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
6
41
1.46
0.50
1.2
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
6
41
1.46
0.50
1.2
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
41
1.46
0.50
1.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
22
171
1.29
0.49
1.0
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
12
84
1.43
0.49
1.0
1.0
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
19
145
1.31
0.48
1.3
1.5
ug/l
6.0
9.0
1.14
19
124
(3037556) Urate [Mass/volume] in Serum or Plasma
7
109
0.64
0.48
1.0
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
46
1.52
0.48
1.3
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
14
189
0.74
0.48
2.2
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
26
208
1.25
0.47
1.1
1.4
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
14
102
1.37
0.47
1.1
1.2
u/ml
0.4
40.8
—
9
63
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
18
137
1.32
0.47
1.4
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
68
1.47
0.47
1.2
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
23
288
0.80
0.46
2.3
2.3
u/field
3.3
2.0
—
7
105
(3006184) Hemoglobin [Mass/volume] in Capillary blood
70
792
0.88
0.46
2.1
2.2
g/l
130.8
128.2
0.43
49
580
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
13
176
0.74
0.46
1.5
1.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
8
118
0.68
0.45
1.1
1.2
—
0.3
—
0
9
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
18
138
1.31
0.45
1.2
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
47
403
1.17
0.45
1.1
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
54
469
1.15
0.44
1.1
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
7
51
1.37
0.44
1.7
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
68
767
0.88
0.43
1.8
1.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
63
714
0.88
0.43
1.7
1.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
13
95
1.37
0.43
1.2
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
90
811
1.11
0.43
1.1
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
11
78
1.41
0.43
1.4
1.4
ug/l
9.4
9.5
0.01
11
78
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
31
257
1.21
0.43
1.1
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
29
239
1.22
0.42
5.5
5.0
u/ml
359.9
39.3
0.45
12
63
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
45
387
1.16
0.42
1.4
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
992
9668
1.04
0.42
4.6
4.0
ph
7.4
7.4
0.12
188
1831
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
32
1.56
0.42
1.4
1.5
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
31
258
1.20
0.41
1.6
1.5
u/l
13.2
13.5
0.10
31
246
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
5
33
1.52
0.41
7.2
5.3
ug/min
36.8
50.6
—
5
26
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
0
17
0.00
0.40
0.0
1.1
—
1.0
—
0
12
(40768446) Kidney Pathology biopsy report
15
114
1.32
0.40
1.5
1.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
24
195
1.23
0.40
1.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
34
1.47
0.40
1.8
1.5
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
60
1.33
0.40
1.0
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
105
959
1.10
0.40
3.2
3.5
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
28
232
1.21
0.39
1.2
2.0
mmol/l
7.6
6.7
0.38
21
155
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
61
1.31
0.39
1.1
1.0
—
—
—
0
0
(3026782) Osmolality of Urine
678
6574
1.04
0.39
3.0
2.9
mosm/kgh2o
552.5
550.7
0.07
570
5599
(3000492) Spirometry study
271
2572
1.06
0.38
1.5
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
42
363
1.16
0.38
1.0
1.1
u/ml
4.2
2.2
—
8
133
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
66
1.36
0.38
1.1
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
37
317
1.17
0.37
1.1
1.1
u/ml
2.7
5.2
0.81
23
136
(3012441) Differential panel - Pleural fluid
44
383
1.15
0.37
1.5
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
169
1804
0.93
0.37
2.9
2.8
e6/l
0.4
0.3
0.06
164
1765
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
41
355
1.16
0.37
1.0
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
41
355
1.16
0.37
1.4
1.4
mosm/kgh2o
278.7
278.6
0.01
24
261
(3023430) Cat dander IgE Ab [Units/volume] in Serum
34
290
1.17
0.36
1.1
1.1
u/ml
8.7
6.9
0.15
22
132
(3014051) Protein [Presence] in Urine by Test strip
82
744
1.10
0.36
2.4
2.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
9
70
1.29
0.36
1.3
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
28
235
1.19
0.36
1.6
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
55
488
1.13
0.36
1.2
1.2
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
19
234
0.81
0.35
1.1
1.2
—
260.0
—
0
7
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
77
698
1.11
0.35
3.4
3.3
u/ml
443.5
889.2
0.41
67
644
(3011412) CD3 cells [#/volume] in Blood
33
282
1.17
0.35
1.8
2.6
e9/l
1.5
1.1
0.70
15
172
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
14
108
1.30
0.35
3.3
2.9
ug/l
1.6
1.5
0.01
14
102
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
43
1.40
0.35
1.0
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
32
273
1.17
0.35
2.3
2.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
32
273
1.17
0.35
1.2
1.1
u/ml
1.8
0.4
0.36
14
91
(3035880) pH of Pleural fluid
17
211
0.80
0.34
1.4
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
18
145
1.24
0.33
1.1
1.2
—
—
—
0
0
(4306422)
42
368
1.14
0.33
1.3
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
29
339
0.85
0.33
3.3
3.7
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
88
0.68
0.33
1.2
1.2
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
26
219
1.19
0.33
1.0
1.0
ng/l
778.5
679.7
0.50
15
139
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
26
219
1.19
0.33
1.0
1.0
ng/l
30.1
44.6
1.69
15
140
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
102
942
1.09
0.33
3.1
3.0
%
92.8
89.6
0.77
95
897
(3022689) Creatine [Moles/volume] in Urine
10
74
1.35
0.32
1.1
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
245
2337
1.05
0.31
4.0
4.0
%
0.0
0.3
0.73
70
586
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
208
0.82
0.31
1.4
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
55
494
1.12
0.31
1.4
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
24
202
1.19
0.31
1.6
1.9
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
70
638
1.10
0.30
1.4
1.8
nmol/l
0.8
0.8
0.05
49
522
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
42
473
0.89
0.30
1.2
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1016
9968
1.03
0.29
3.9
3.4
e6/l
113.4
86.0
0.25
786
7750
(3038177) Helicobacter pylori Ab [Presence] in Serum
46
411
1.12
0.29
1.2
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
34
387
0.88
0.28
1.4
1.2
u/ml
9.1
3.6
—
9
130
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
10
76
1.32
0.28
2.9
2.5
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
12
94
1.28
0.28
3.4
2.4
%
164.8
177.8
0.15
12
86
(3033799) Differential panel - Peritoneal fluid
12
94
1.28
0.28
1.5
1.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
194
1847
1.05
0.28
4.9
4.6
mmol/l
23.8
24.0
0.49
182
1676
(40767503) Oxygen content in Capillary blood by calculation
68
741
0.92
0.27
2.7
2.5
%
16.8
16.1
0.85
35
389
(3035320) C reactive protein [Mass/volume] in Body fluid
27
233
1.16
0.27
2.5
2.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
23
196
1.17
0.27
3.8
3.7
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
45
404
1.12
0.26
1.0
1.1
g/l
1.5
1.5
0.55
39
370
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
40
357
1.12
0.26
1.3
1.4
—
—
—
0
0
(4198724)
12
95
1.26
0.26
1.5
1.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
214
0.84
0.26
2.2
2.7
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
12
149
0.80
0.25
1.1
1.2
u/ml
0.5
16.0
—
7
63
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
40
358
1.12
0.25
1.3
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
27
235
1.15
0.25
1.6
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
204
2130
0.96
0.24
1.5
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
76
1.18
0.24
1.1
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
40
359
1.12
0.24
1.3
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
28
318
0.88
0.24
2.2
2.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
34
303
1.12
0.23
1.4
1.3
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
25
218
1.15
0.23
1.0
1.0
ng/l
213.0
309.2
2.08
14
142
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
13
106
1.23
0.23
2.5
2.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
39
1.28
0.23
1.0
1.5
umol/l
46.2
42.2
—
5
39
(4027681)
19
162
1.17
0.22
1.1
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
73
784
0.93
0.22
1.9
1.9
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
19
221
0.86
0.22
1.3
1.3
mmol/l
13.9
12.1
—
10
60
(40768793) Breast Pathology biopsy report
66
612
1.08
0.22
1.5
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
15
178
0.84
0.22
1.4
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
399
3885
1.03
0.21
1.9
1.8
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
3.6
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
56
606
0.92
0.21
2.1
2.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
264
2729
0.96
0.21
4.4
3.8
mmol/l
1.2
1.2
0.70
231
2366
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.3
—
0.3
—
0
6
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
57
616
0.92
0.21
4.7
3.7
%
59.8
57.5
0.81
57
616
(3027008) Opiates [Presence] in Urine
73
781
0.93
0.21
1.9
2.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
25
283
0.88
0.21
1.2
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
103
0.78
0.21
1.3
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
43
1.16
0.21
1.2
1.0
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
8
105
0.76
0.21
2.5
2.3
%
8.9
7.4
—
8
99
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
2.8
—
4.0
—
0
13
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
89
1.24
0.21
1.0
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
17
198
0.86
0.20
1.9
2.5
ph
7.4
7.4
—
6
64
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
10
80
1.25
0.20
1.1
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
48
1.25
0.20
1.2
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
74
789
0.94
0.20
4.3
3.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
38
417
0.91
0.19
1.2
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
691
7033
0.98
0.19
2.9
2.7
e6/l
5.7
5.1
0.45
612
6175
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
30
269
1.12
0.19
1.1
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
20
174
1.15
0.19
2.3
1.7
u/field
0.4
3.6
—
8
123
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
6
51
1.18
0.19
1.3
1.9
ng/l
121.0
145.6
—
6
51
(3021589) Normoblasts [#/volume] in Blood
1336
13506
0.98
0.19
10.6
10.0
e9/l
0.0
0.0
1.14
1082
10957
(3028308) Erythrocytes [#/volume] in Pleural fluid
45
414
1.09
0.19
1.5
1.4
e6/l
30918.8
66074.7
1.01
30
250
(44806118)
34
374
0.91
0.18
1.4
1.5
—
—
—
0
0
(44790047)
34
374
0.91
0.18
1.4
1.5
—
—
—
0
0
(44790049)
34
374
0.91
0.18
1.4
1.5
—
—
—
0
0
(44790048)
34
374
0.91
0.18
1.4
1.5
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
10
81
1.24
0.18
1.3
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
73
776
0.94
0.18
1.9
2.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
42
386
1.09
0.18
1.4
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
52
483
1.08
0.18
1.1
1.1
iu/ml
26.3
78.8
—
9
109
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
39
358
1.09
0.17
1.3
1.4
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
12
142
0.84
0.17
1.2
1.4
%
—
67.5
—
0
18
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
29
262
1.11
0.17
1.6
1.3
u/l
11.1
13.6
0.58
29
240
(3001019) Free T4 and TSH panel - Serum or Plasma
93
978
0.95
0.17
1.5
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
64
681
0.94
0.17
2.9
3.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
10
82
1.22
0.17
3.7
1.7
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
18
158
1.14
0.16
1.2
1.1
u/l
1.0
1.2
2.33
12
83
(3012501) Base excess in Blood by calculation
72
761
0.95
0.16
4.5
5.0
mmol/l
2.7
2.8
0.04
47
526
(3045788) Cell count panel - Pleural fluid
33
360
0.92
0.16
1.4
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
42
389
1.08
0.16
1.6
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
8
72
1.11
0.16
1.5
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
84
883
0.95
0.16
2.0
1.8
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
73
1.10
0.15
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
56
526
1.07
0.15
2.6
2.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
25
276
0.91
0.15
2.2
4.1
%
11.5
11.1
0.27
25
276
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
14
121
1.16
0.15
2.5
2.7
umol/l
50.8
120.2
—
8
72
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
82
1.10
0.15
1.3
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
9
83
1.08
0.14
1.7
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
188
1826
1.03
0.14
1.6
1.6
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
10
118
0.85
0.14
4.8
4.3
%
44.2
54.2
—
10
113
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
47
501
0.94
0.14
1.8
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
8
99
0.81
0.13
2.5
2.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
60
568
1.06
0.13
1.3
1.2
u/l
48.4
45.4
0.04
48
491
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
27
247
1.09
0.13
1.3
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
191
1858
1.03
0.13
1.8
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
641
6494
0.98
0.13
3.9
3.9
ng/l
495.3
560.8
0.13
510
5362
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
21
190
1.11
0.12
1.2
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
21
190
1.11
0.12
1.2
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
208
2131
0.97
0.12
3.5
3.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
44
414
1.06
0.12
1.1
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
15
133
1.13
0.12
1.4
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
48
454
1.06
0.11
1.5
1.5
e6/l
3023.1
1966.1
0.29
39
330
(3000991) Gas panel - Venous blood
295
3006
0.98
0.11
8.1
7.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
918
9098
1.01
0.11
3.8
3.3
e6/l
0.5
0.5
0.01
695
6940
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
35
328
1.07
0.11
1.2
1.3
mmol/l
6.8
7.5
0.63
26
233
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
45
426
1.06
0.10
3.5
2.4
u/ml
25.8
1070.1
0.87
45
408
(3024928) Oxygen saturation in Venous blood
69
718
0.96
0.10
3.0
3.5
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
25
269
0.93
0.10
2.8
2.2
ml
670.4
624.9
0.19
15
166
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
12
106
1.13
0.09
1.2
1.0
%
87.3
94.1
—
6
82
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
116
1.12
0.09
3.1
2.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
63
655
0.96
0.09
1.8
1.7
e6/l
4.7
24.3
1.40
45
510
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
63
655
0.96
0.09
1.8
1.8
e6/l
1024.8
680.2
0.25
48
536
(3018095) Leukocytes [#/volume] in Urine
1152
11447
1.01
0.09
4.4
3.9
e6/l
77.7
114.3
1.44
832
8260
(3021879) Hepatitis B virus core Ab [Presence] in Serum
188
1843
1.02
0.09
1.3
1.4
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
6
55
1.09
0.08
5.7
6.7
g/mol
123.2
66.6
—
6
47
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
56
1.07
0.08
1.2
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
58
1.03
0.08
2.2
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
10
88
1.14
0.08
2.1
1.9
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
7
66
1.06
0.08
1.4
1.4
g/l
33.3
26.5
—
7
53
(3020650) Glucose [Presence] in Urine
6
71
0.84
0.07
1.2
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
40
382
1.05
0.07
1.2
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
8
76
1.05
0.07
1.4
1.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
112
0.89
0.07
1.4
2.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
112
0.89
0.07
1.4
2.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
38
363
1.05
0.07
1.1
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
15
163
0.92
0.07
1.2
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
70
721
0.97
0.07
1.9
2.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
91
0.88
0.06
1.1
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
92
0.87
0.06
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
8
93
0.86
0.06
1.0
1.0
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
14
128
1.09
0.06
2.6
1.7
nmol/l
3.4
9.1
—
9
108
(44813793)
19
177
1.07
0.06
1.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
11
99
1.11
0.06
1.3
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
27
284
0.95
0.06
1.3
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
38
365
1.04
0.06
1.1
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
28
293
0.96
0.05
2.1
1.4
%
39.3
27.3
0.59
15
183
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
71
693
1.03
0.05
1.4
1.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
36
373
0.96
0.04
1.5
1.3
pmol/l
200.5
275.8
1.90
27
279
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
126
1241
1.02
0.04
1.5
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
790
7935
0.99
0.04
6.5
6.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
47
457
1.03
0.04
1.4
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
109
0.92
0.04
1.4
1.6
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
13
121
1.07
0.03
2.4
2.3
ug/l
57.1
74.6
0.45
13
116
(1617658) Protocol used for examination of sentinel lymph nodes
23
220
1.05
0.03
1.1
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
46
472
0.97
0.03
1.5
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
13
139
0.94
0.03
1.2
1.0
—
—
—
0
0
(4281824)
30
290
1.03
0.03
1.3
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
17
179
0.95
0.03
1.4
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
20
209
0.96
0.03
1.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
38
370
1.03
0.03
1.2
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
61
599
1.02
0.02
1.4
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
28
271
1.03
0.02
1.5
1.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
28
289
0.97
0.02
2.8
3.2
mg/l
85.9
27.2
0.43
20
224
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
30
309
0.97
0.02
1.5
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
36
352
1.02
0.01
2.5
2.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
42
427
0.98
0.01
1.3
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
112
1113
1.01
0.00
2.1
1.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
28
286
0.98
0.00
1.3
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77
764
1.01
0.00
1.3
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
11
108
1.02
0.00
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
14
138
1.01
0.00
1.1
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
17
172
0.99
0.00
6.7
3.7
—
—
—
0
0
(3016750) Collection duration of Urine
19
188
1.01
0.00
2.9
2.0
min
502.4
492.5
0.19
11
134
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
23
228
1.01
0.00
1.5
1.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
12
115
1.04
0.00
2.3
2.4
—
—
—
0
0
(3000012) Reticulocyte production index
19
185
1.03
0.00
1.4
1.5
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
37
365
1.01
0.00
1.2
1.1
%
124.6
113.3
1.03
30
330
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
38
375
1.01
0.00
1.3
1.2
u/ml
5.3
5.1
0.02
19
169
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
132
1318
1.00
0.00
4.4
3.5
u/ml
28.9
68.5
5.18
124
1266
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
19
189
1.01
0.00
1.5
1.2
—
—
—
0
0
(4268621)
26
259
1.00
0.00
2.7
2.3
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
40
404
0.99
0.00
1.7
1.4
mu/l
144.6
54.9
0.60
30
353
(3043238) Trisomy 21 risk [Likelihood] in Fetus
29
293
0.99
0.00
1.3
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
53
533
0.99
0.00
1.2
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
73
727
1.00
0.00
1.2
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
22
217
1.01
0.00
2.0
2.7
%
18.8
13.0
0.48
13
114
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
13
133
0.98
0.00
1.2
1.2
iu/ml
362.6
217.5
0.55
13
133
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
9
0.00
0.00
0.0
6.4
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
9
0.00
0.00
0.0
3.9
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
7
0.00
0.00
0.0
1.0
—
1293.0
—
0
7
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
1.6
—
0
5
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
49
1.02
0.00
3.6
2.5
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
1270.0
—
0
5
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043722) Hyaline casts [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
1.0
—
1.0
—
0
5
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
7
71
0.99
0.00
1.4
1.4
nmol/l
26.4
36.0
—
7
57
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
7
0.00
0.00
0.0
6.1
—
98.1
—
0
7
(40757373) Influenza virus identified in Isolate
8
86
0.93
0.00
1.5
1.5
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
11
110
1.00
0.00
1.1
2.1
—
32045.5
—
0
15
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
9
91
0.99
0.00
1.2
1.2
%
—
21.4
—
0
12
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
49
1.02
0.00
7.2
5.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
79
0.89
0.00
1.1
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
68
0.88
0.00
1.0
1.0
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
6
63
0.95
0.00
1.0
1.2
mg/l
1.0
75.5
—
6
47
(3042733) HLA Ab [Presence] in Serum
8
81
0.99
0.00
6.0
4.3
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
60
1.00
0.00
1.2
1.6
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
53
0.94
0.00
3.4
1.1
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
8
86
0.93
0.00
1.3
2.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H8_CERUMEN and mortality.

Females

Parameter HR [95% CI] p-value
H8_CERUMEN 1.112 [0.97, 1.27] 0.114
Birth year 0.996 [0.99, 1.0] 0.302

During the follow-up period (1.1.1998 — 31.12.2019), 1825 out of 8627 females with H8_CERUMEN died.

Males

Parameter HR [95% CI] p-value
H8_CERUMEN 1.225 [1.06, 1.42] 0.006
Birth year 0.989 [0.98, 1.0] 0.02

During the follow-up period (1.1.1998 — 31.12.2019), 1919 out of 8943 males with H8_CERUMEN died.

Mortality risk

Mortality risk for people of age

years, who have H8_CERUMEN.

N-year risk Females Males
1 0.092% 0.232%
5 0.661% 1.536%
10 1.651% 3.767%
15 3.381% 7.112%
20 5.82% 11.886%

Relationships between endpoints

↥

Index endpoint: H8_CERUMEN – Impacted cerumen

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data